PAAMCP
VRTX icon

Pacific Alternative Asset Management Company (PAAMCO)’s Vertex Pharmaceuticals VRTX Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,699
Closed -$1.2M – 183
2014
Q3 		$1.2M Buy
10,699
+3,665
+52% +$349K 0.14% 135
2014
Q2 		$666K Buy
+7,034
New +$493K 0.08% 155

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s VRTX Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Vertex Pharmaceuticals (VRTX) in Q4 2014, closing a stake of 10,699 shares — an estimated $1.2M sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in VRTX in Q2 2014 and held it in 2 quarters. The position peaked at $1.2M in Q3 2014. 475 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Vertex Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 10,699 Vertex Pharmaceuticals shares in Q4 2014, an estimated $1.2M.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Vertex Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Vertex Pharmaceuticals position peaked at $1.2M in Q3 2014.
  • 475 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.